Cell Source, Inc. SEC filings CLCS
Cell Source, Inc. has 139 filings in SEC EDGAR's recent list, going back to Mar 5, 2013. Its latest annual report, Form 10-K, was filed on Apr 7, 2026 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Jun 27, 2025 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Mar 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Officer or director change
|
May 6, 2022 | May 6, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Mar 11, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2019 | Apr 19, 2019 |
| 8-K |
Current report
Other events
|
Nov 16, 2015 | Nov 14, 2015 |
| 8-K |
Current report
Other events
|
Nov 5, 2015 | Nov 4, 2015 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2015 | Aug 19, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 28, 2015 | Jul 20, 2015 |
| 8-K |
Current report
Material agreement
|
Jun 10, 2015 | Jun 4, 2015 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 3, 2015 | May 15, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2015 | May 28, 2015 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Apr 1, 2015 | Mar 26, 2015 |
| 8-K |
Current report
New debt
|
Dec 2, 2014 | Nov 26, 2014 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Shareholder vote results
|
Jul 1, 2014 | Jun 30, 2014 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 30, 2014 | Jun 27, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2014 | Jun 23, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2014 | May 7, 2014 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLCS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1569340
- Former names
- TICKET TO SEE, INC. (until Jun 26, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.